Perceptive Advisors LLC 13F holdings, Q3 2024
Holdings as of September 30, 2024 · filings on SEC EDGAR · latest filing →
Perceptive Advisors LLC disclosed 102 US equity positions worth $4.7bn in its Q3 2024 13F filing. The largest position was ACLXGBX at 7.0% of the reported book, followed by NUVALENT INC and AM6.
What did Perceptive Advisors LLC own in Q3 2024? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs prior |
|---|---|---|---|---|---|---|---|
| 1 | ACLXGBX ARCELLX INC | 7.0% | $324.7m | 3,888,669 | – | ||
| 2 | NUVALENT INC | 6.5% | $304.8m | 2,979,235 | – | ||
| 3 | AM6 AMICUS THERAPEUTICS INC | 6.4% | $299.7m | 28,057,456 | – | ||
| 4 | IOVA IOVANCE BIOTHERAPEUTICS INC | Healthcare | 5.4% | $249.9m | 26,617,709 | – | |
| 5 | PCVX VAXCYTE INC | Healthcare | 5.0% | $231.7m | 2,027,608 | – | |
| 6 | RYTM RHYTHM PHARMACEUTICALS INC | Healthcare | 4.0% | $186.5m | 3,560,214 | – | |
| 7 | VRNA VERONA PHARMA PLC | 3.9% | $181.7m | 6,315,933 | – | ||
| 8 | SLNOEUR SOLENO THERAPEUTICS INC | 3.5% | $161.8m | 3,204,976 | – | ||
| 9 | ITCIEUR INTRA-CELLULAR THERAPIES INC | 2.5% | $118.7m | 1,622,215 | – | ||
| 10 | APGE APOGEE THERAPEUTICS INC | Healthcare | 2.5% | $118.4m | 2,015,007 | – | |
| 11 | VKTX VIKING THERAPEUTICS INC | Healthcare | 2.3% | $107.6m | 1,699,987 | – | |
| 12 | CNTA CENTESSA PHARMACEUTICALS PLC | 2.2% | $100.5m | 6,282,290 | – | ||
| 13 | IMTX IMMATICS N.V | Healthcare | 2.0% | $92.3m | 8,086,159 | – | |
| 14 | EOLS EVOLUS INC | Healthcare | 1.9% | $86.8m | 5,356,622 | – | |
| 15 | SYRE SPYRE THERAPEUTICS INC | 1.8% | $84.5m | 2,872,547 | – | ||
| 16 | AORT ARTIVION INC | Healthcare | 1.6% | $74.4m | 2,793,703 | – | |
| 17 | BHVN BIOHAVEN LTD | Healthcare | 1.6% | $74.2m | 1,485,232 | – | |
| 18 | CATBUSD ASTRIA THERAPEUTICS INC | 1.5% | $71.4m | 6,485,420 | – | ||
| 19 | AXSM AXSOME THERAPEUTICS INC | Healthcare | 1.5% | $70.4m | 782,844 | – | |
| 20 | APLT APPLIED THERAPEUTICS INC | 1.5% | $68.0m | 8,005,000 | – | ||
| 21 | CRGX CARGO THERAPEUTICS INC | 1.5% | $68.0m | 3,683,004 | – | ||
| 22 | IMVT IMMUNOVANT INC | Healthcare | 1.5% | $67.8m | 2,378,762 | – | |
| 23 | PRAX PRAXIS PRECISION MEDICINES I | Healthcare | 1.4% | $67.0m | 1,164,035 | – | |
| 24 | ARGX ARGENX SE | Healthcare | 1.4% | $64.4m | 118,839 | – | |
| 25 | VRDN VIRIDIAN THERAPEUTICS INC | Healthcare | 1.4% | $64.0m | 2,812,665 | – | |
| 26 | EWTX EDGEWISE THERAPEUTICS INC | 1.3% | $62.2m | 2,330,294 | – | ||
| 27 | PTGX PROTAGONIST THERAPEUTICS INC | Healthcare | 1.3% | $61.9m | 1,374,563 | – | |
| 28 | MGTX MEIRAGTX HLDGS PLC | 1.1% | $52.4m | 12,581,103 | – | ||
| 29 | ALDX ALDEYRA THERAPEUTICS INC | Healthcare | 1.1% | $50.0m | 9,275,851 | – | |
| 30 | AKERO THERAPEUTICS INC | 1.1% | $49.2m | 1,714,806 | – | ||
| 31 | SLDB SOLID BIOSCIENCES INC | Healthcare | 1.0% | $48.1m | 6,906,646 | – | |
| 32 | TARS TARSUS PHARMACEUTICALS INC | Healthcare | 0.9% | $42.6m | 1,296,416 | – | |
| 33 | ACRV ACRIVON THERAPEUTICS INC | 0.8% | $37.5m | 5,360,858 | – | ||
| 34 | CRNXGBP CRINETICS PHARMACEUTICALS IN | 0.8% | $37.0m | 724,698 | – | ||
| 35 | NAUT NAUTILUS BIOTECHNOLOGY INC | 0.8% | $35.9m | 12,594,211 | – | ||
| 36 | CELC CELCUITY INC | Healthcare | 0.8% | $35.2m | 2,362,279 | – | |
| 37 | PODD INSULET CORP | Healthcare | 0.7% | $33.1m | 142,269 | – | |
| 38 | ORKA ORUKA THERAPEUTICS INC | Healthcare | 0.6% | $30.3m | 1,235,187 | – | |
| 39 | CTNM CONTINEUM THERAPEUTICS INC | 0.6% | $29.0m | 1,516,668 | – | ||
| 40 | OCUL OCULAR THERAPEUTIX INC | Healthcare | 0.6% | $28.9m | 3,324,468 | – | |
| 41 | ISRG INTUITIVE SURGICAL INC | Healthcare | 0.6% | $28.6m | 58,119 | – | |
| 42 | NTRA NATERA INC | Healthcare | 0.6% | $27.9m | 220,000 | – | |
| 43 | CGON CG ONCOLOGY INC | Healthcare | 0.6% | $27.7m | 733,695 | – | |
| 44 | ZYME ZYMEWORKS INC | Healthcare | 0.6% | $27.4m | 2,180,020 | – | |
| 45 | DYN DYNE THERAPEUTICS INC | Healthcare | 0.6% | $25.8m | 718,144 | – | |
| 46 | ADGM ADAGIO MED HLDGS INC | 0.5% | $25.3m | 9,812,419 | – | ||
| 47 | ARVN ARVINAS INC | Healthcare | 0.5% | $25.3m | 1,027,749 | – | |
| 48 | PRCT PROCEPT BIOROBOTICS CORP | Healthcare | 0.5% | $25.3m | 315,659 | – | |
| 49 | NBIX NEUROCRINE BIOSCIENCES INC | Healthcare | 0.5% | $24.5m | 212,228 | – | |
| 50 | OBIO ORCHESTRA BIOMED HLDGS INC | 0.5% | $23.6m | 4,592,556 | – |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.